Stephen Willey
Stock Analyst at Stifel
(3.96)
# 542
Out of 5,172 analysts
132
Total ratings
44.33%
Success rate
13.2%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Stephen Willey
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ZYME Zymeworks | Maintains: Buy | $40 → $47 | $23.90 | +96.69% | 8 | Mar 3, 2026 | |
| ACLX Arcellx | Downgrades: Hold | $127 → $115 | $114.33 | +0.59% | 2 | Feb 24, 2026 | |
| IRON Disc Medicine | Maintains: Buy | $125 → $110 | $59.17 | +85.91% | 2 | Feb 17, 2026 | |
| INCY Incyte | Maintains: Buy | $119 → $120 | $92.95 | +29.10% | 8 | Feb 11, 2026 | |
| EXEL Exelixis | Maintains: Hold | $43 → $44 | $41.26 | +6.64% | 20 | Feb 11, 2026 | |
| NRIX Nurix Therapeutics | Maintains: Buy | $33 → $35 | $14.92 | +134.58% | 6 | Jan 29, 2026 | |
| CELC Celcuity | Maintains: Buy | $68 → $115 | $112.99 | +1.78% | 2 | Nov 13, 2025 | |
| NKTX Nkarta | Maintains: Buy | $12 → $11 | $2.17 | +406.91% | 5 | Nov 11, 2025 | |
| XFOR X4 Pharmaceuticals | Maintains: Buy | $30 → $9 | $4.17 | +115.83% | 3 | Aug 29, 2025 | |
| INSM Insmed | Maintains: Buy | $121 → $145 | $144.00 | +0.69% | 8 | Aug 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $7 | $3.53 | +98.30% | 7 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $28 | $10.57 | +165.03% | 1 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $6 → $5 | $2.90 | +72.41% | 4 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $25 → $20 | $4.54 | +340.53% | 4 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $240 → $100 | $13.17 | +659.30% | 5 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $4 | $1.55 | +158.06% | 3 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $47 | $18.79 | +150.13% | 1 | Oct 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $4 | $0.26 | +1,414.00% | 7 | Aug 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $4 | $2.11 | +89.57% | 1 | Dec 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $53 → $62 | $55.17 | +12.38% | 5 | Dec 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $5.39 | +66.98% | 1 | Jan 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $1.84 | +552.17% | 1 | Nov 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $228 → $288 | $1.65 | +17,354.55% | 4 | Jun 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $21 | $2.47 | +750.20% | 2 | Mar 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $10 → $4 | $1.62 | +146.91% | 7 | Jul 29, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $125 → $123 | $311.10 | -60.46% | 3 | Aug 13, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $48 → $47 | $71.32 | -34.10% | 2 | Aug 8, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $102 → $109 | $55.03 | +98.07% | 3 | Aug 3, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Terminates: Hold | n/a | $22.09 | - | 2 | Jun 25, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $23 | $6.97 | +229.99% | 5 | Feb 7, 2018 |
Zymeworks
Mar 3, 2026
Maintains: Buy
Price Target: $40 → $47
Current: $23.90
Upside: +96.69%
Arcellx
Feb 24, 2026
Downgrades: Hold
Price Target: $127 → $115
Current: $114.33
Upside: +0.59%
Disc Medicine
Feb 17, 2026
Maintains: Buy
Price Target: $125 → $110
Current: $59.17
Upside: +85.91%
Incyte
Feb 11, 2026
Maintains: Buy
Price Target: $119 → $120
Current: $92.95
Upside: +29.10%
Exelixis
Feb 11, 2026
Maintains: Hold
Price Target: $43 → $44
Current: $41.26
Upside: +6.64%
Nurix Therapeutics
Jan 29, 2026
Maintains: Buy
Price Target: $33 → $35
Current: $14.92
Upside: +134.58%
Celcuity
Nov 13, 2025
Maintains: Buy
Price Target: $68 → $115
Current: $112.99
Upside: +1.78%
Nkarta
Nov 11, 2025
Maintains: Buy
Price Target: $12 → $11
Current: $2.17
Upside: +406.91%
X4 Pharmaceuticals
Aug 29, 2025
Maintains: Buy
Price Target: $30 → $9
Current: $4.17
Upside: +115.83%
Insmed
Aug 14, 2025
Maintains: Buy
Price Target: $121 → $145
Current: $144.00
Upside: +0.69%
Aug 8, 2025
Maintains: Buy
Price Target: $8 → $7
Current: $3.53
Upside: +98.30%
Jun 25, 2025
Initiates: Buy
Price Target: $28
Current: $10.57
Upside: +165.03%
May 14, 2025
Maintains: Hold
Price Target: $6 → $5
Current: $2.90
Upside: +72.41%
May 13, 2025
Maintains: Hold
Price Target: $25 → $20
Current: $4.54
Upside: +340.53%
Mar 21, 2025
Maintains: Buy
Price Target: $240 → $100
Current: $13.17
Upside: +659.30%
Feb 27, 2025
Maintains: Buy
Price Target: $8 → $4
Current: $1.55
Upside: +158.06%
Oct 8, 2024
Initiates: Buy
Price Target: $47
Current: $18.79
Upside: +150.13%
Aug 20, 2024
Maintains: Buy
Price Target: $8 → $4
Current: $0.26
Upside: +1,414.00%
Dec 19, 2023
Maintains: Buy
Price Target: $3 → $4
Current: $2.11
Upside: +89.57%
Dec 18, 2023
Maintains: Buy
Price Target: $53 → $62
Current: $55.17
Upside: +12.38%
Jan 27, 2023
Initiates: Buy
Price Target: $9
Current: $5.39
Upside: +66.98%
Nov 28, 2022
Initiates: Buy
Price Target: $12
Current: $1.84
Upside: +552.17%
Jun 26, 2020
Downgrades: Hold
Price Target: $228 → $288
Current: $1.65
Upside: +17,354.55%
Mar 17, 2020
Maintains: Buy
Price Target: $22 → $21
Current: $2.47
Upside: +750.20%
Jul 29, 2019
Downgrades: Hold
Price Target: $10 → $4
Current: $1.62
Upside: +146.91%
Aug 13, 2018
Maintains: Buy
Price Target: $125 → $123
Current: $311.10
Upside: -60.46%
Aug 8, 2018
Maintains: Hold
Price Target: $48 → $47
Current: $71.32
Upside: -34.10%
Aug 3, 2018
Maintains: Buy
Price Target: $102 → $109
Current: $55.03
Upside: +98.07%
Jun 25, 2018
Terminates: Hold
Price Target: n/a
Current: $22.09
Upside: -
Feb 7, 2018
Maintains: Buy
Price Target: $20 → $23
Current: $6.97
Upside: +229.99%